@aimhiaccelerator

aimhiaccelerator has been a member of Linktree for 4 years and joined in June 2022. The social media accounts linked to from aimhiaccelerator are: • Facebook • Instagram • LinkedIn • Email • X Besides social media accounts, aimhiaccelerator has populated their site with: • AIM-HI Accelerator Fund Announces the 2024 Women’s Venture Competition Winners - AIM-HI Accelerator • 2022 Winner to Szent-Györgyi Prize for Progress in Cancer Research • AACR CEO Dr. Margaret Foti Selected as the 2024 Beacon Award Winner for her Significant Impact in the Fight against Cancer - AIM-HI • 2022 Precision Medicine and Functional Genomics • AIM-HI Accelerator Fund Announces Lance Kawaguchi, CEO of Cure Brain Cancer Foundation, as New Strategic Advisor - AIM-HI • Support AIM-HI • AIM-HI Accelerator Fund Celebrates Yiviva's Milestone Collaboration With Astrazeneca China, Furthering Technology Platforms For Multiple Cancers - AIM-HI • STREAM NOW on the Oncology Metaverse - 2022 Global Summit for Cancer Research • National Cancer Institute (NCI) Director, Monica M. Bertagnolli, M.D., Selected as the Recipient of the 2023 AIM-HI Beacon Award for Women Leaders in Oncology - AIM-HI • Women's Venture Competition Online Application - AIM-HI • 2023 AIM HI Women’s Venture Competition - SuviCa • Nomination for Beacon Award for Women Leaders in Oncology • People's Choice Award 2023 - AIM-HI • 2023 AIM HI Women’s Venture Competition - PDX Pharmaceuticals • CEO Sujuan Ba Featured Speaker at SupChina Women's Gala & Conference 2023 • 2023 AIM HI Women’s Venture Competition - March Biosciences • Tvardi Therapeutics Announces Presentation of Data from the Phase 1 Trial of TTI-101, a STAT3 Inhibitor, in Advanced Solid Tumors at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting • 2023 AIM HI Women’s Venture Competition - Delee • National Foundation for Cancer Research Giving Day • 2023 AIM HI Women’s Venture Competition - Degron Therapeutics • Beacon Award for Women Leaders in Oncology - AIM-HI • 2023 AIM HI Women’s Venture Competition - Apeximmune Therapeutics • Dr Anna Barker to speak at Translational Systems Biology symposium • How We Can Empower Women-Owned Business Ventures And Help Resolve Economic Disparities • AIM-HI Accelerator Fund Welcomes New Leadership and Members to Its Board of Directors - AIM-HI • A Shared Vision - AngeLink Powered by Women Series - AIM-HI • AIM-HI South Pole Trek 4 Cancer • Privo Technologies, Inc. Receives IRB Approval for PRV211- Intraoperative Chemotherapy Treatment for Solid Tumors - Privo Technologies, Inc. • AIM-HI Part of South Pole Trek 4 Cancer Nasdaq Closing Bell Ceremony • AIM-HI Accelerator Fund Honors Anna D. Barker, Ph.D., with Inaugural Beacon Award for Women Leaders in Oncology • Venture Competitions - AIM-HI • Support and VOTE for AIM-HI Network Believer Pharmaceuticals for the BRIght Futures Prize • AIM-HI Accelerator Fund x AngeLink Donation • CEO Sujuan Ba Speaking at the Longwood Healthcare Leaders Web Conference • Privo Technologies News • Sujuan Ba PhD as Panelist at the 2022 NCI Technology Showcase • The Galien Foundation Announces 2022 Prix Galien USA Nominees for "Best Digital Health Solution," "Incubators, Accelerators and Equity," and "Prix Galien Startup" • AmazonSmile: AIM-HI Accelerator Fund • Arbele’s ARB202 Receives Clinical Trial Phase I Ethics Approval in Australia